Reliq Health Technologies Reaches First Major Milestone of 1,000 Patients Live on Its Remote Patient Monitoring and Telemedicine Platform

VANCOUVER, British Columbia, Oct. 05, 2017 -- Reliq Health Technologies Inc. (TSX VENTURE:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it now has 1,000 paid subscribers using its chronic care management, remote patient monitoring and telemedicine solution, representing recurring monthly revenue of US$50,000/month.

“We are excited to announce that we now have 1,000 patients live on our platform,” said Dr. Lisa Crossley, CEO of Reliq Health.  “This is a critical milestone for Reliq as we move forward with our roll out to over 40,000 patients in accordance with our previously-announced contracts with Paz Home Health, LLC (Pharr, TX) and Rio Grande Valley Health Alliance, LLC (McAllen, TX).  We expect to enroll at least 1,000 new patients per month through 2018 with these two contracts, which together are worth over US$26 Million annually in recurring revenue at full deployment.”

Reliq’s digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and tracking medication adherence. Reliq’s interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities.  Reliq’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions.  The Reliq Health cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information contact:

Renmark Financial Communications Inc.
Laura Welsh: [email protected]
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. 

Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.